Tyra Biosciences, Inc.
TYRA
DELAYED 1 MONTH

12 insider filings · Latest: May 28, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 28, 2026Jun 1 9:45 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
13,160$32.6813,160(I)

View →

May 28, 2026Jun 1 8:30 PMRehan VerjeeDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 28, 2026Jun 1 8:30 PMSusan MoranDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 28, 2026Jun 1 8:30 PMJake SimsonDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 28, 2026Jun 1 8:30 PMAdele M. GulfoDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 28, 2026Jun 1 8:30 PMRobert J MoreDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 28, 2026Jun 1 8:30 PMStephen Michael RothenbergDirector
Grant/Award
13,160$32.6813,160(D)

View →

May 5, 2026May 7 8:30 PMDouglas J WarnerChief Medical Officer
Grant/Award
85,000$33.9385,000(D)

View →

May 5, 2026May 7 8:30 PMAlan FuhrmanChief Financial Officer
Grant/Award
67,000$33.9367,000(D)

View →

May 5, 2026May 7 8:30 PMTodd HarrisDirector, President and CEO
Grant/Award
265,000$33.93265,000(D)

View →

May 5, 2026May 7 8:30 PMBhavesh AsharChief Operating Officer
Grant/Award
50,295$33.9350,295(D)

View →

May 5, 2026May 7 8:30 PMYuliya RuebVice President, Finance (PAO)
Grant/Award
28,000$33.9328,000(D)

View →